Chinese Pharmaceuticals & Biotech Undervalued Small Caps

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥11.8b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥12.0b

Engages in the blood product businesses in China.

Beijing Strong BiotechnologiesInc

Market Cap: CN¥7.8b

Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.

Hvsen Biotechnology

Market Cap: CN¥4.0b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥12.0b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

Beijing Kawin Technology Share-Holding

Market Cap: CN¥4.3b

A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally.

Amoy Diagnostics

Market Cap: CN¥8.5b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.